ACE2 gene expression is up-regulated in the human failing heart

BMC Medicine

Volumn 2, Issue , 2004, Pages

  Goulter, Andrew B ^a   Goddard, Martin J ^b   Allen, Jennifer C ^a   Clark, Kenneth L ^a  

^a Pharmagene Laboratories Ltd   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE 2; MESSENGER RNA; RENIN; UNCLASSIFIED DRUG; ANGIOTENSIN CONVERTING ENZYME 2; CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; ALGORITHM; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DONOR; ENZYME REGULATION; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE WALL; HUMAN; HUMAN TISSUE; HYPOTHESIS; IDIOPATHIC DISEASE; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MALE; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; UPREGULATION; AGED; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CARBOXYPEPTIDASES; CARDIOMYOPATHY, DILATED; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; UP-REGULATION;

EID: 4243105120     PISSN: 17417015     EISSN: None     Source Type: Journal    
DOI: 10.1186/1741-7015-2-19     Document Type: Article

References (20)

1. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000, 87:E1-9.
2. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000, 275:33238-33243.
3. Harmer D, Gilbert M, Borman R, Clark KL: Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002, 532:107-110.
4. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P: Hydrolysis of biological peptides by human angiotensinconverting enzyme-related carboxypeptidase. J Biol Chem 2002, 277:14838-14843.
5. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI: Counterregulatory actions of angiotensin-(1-7). Hypertension 1997, 30:535-541.
6. Ferrario CM: Angiotension-(1-7) and antihypertensive mechanisms. J Nephrol 1998, 11:278-283.
7. Boehm M, Nabel EG: Angiotensin-converting enzyme 2-a new cardiac regulator. N Engl J Med 2002, 347:1795-1797.
8. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM: Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002, 417:822-828.
9. Bowen WP, Carey JE, Miah A, McMurray HF, Munday PW, James RS, Coleman RA, Brown AM: Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 2000, 28:781-788.
10. Oudit GY, Crackower MA, Backx PH, Penninger JM: The Role of ACE2 in Cardiovascular Physiology. Trends Cardiovasc Med 2003, 13:93-101.
11. Coleman RA, Clark KL: Target validation using human tissue: from gene expression to function. Targets 2003, 2:58-64.
12. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Obata K, Takemura G, Fujiwara H, Sugawara A, Yamada T, et al.: Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest 1989, 83:298-305.
13. Studer R, Reinecke H, Muller B, Holtz J, Just H, Drexler H: Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 1994, 94:301-310.
14. Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME: Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003, 41:392-397.
15. Haywood GA, Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M, Fowler MB: AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 1997, 95:1201-1206.
16. Regitz-Zagrosek V, Fielitz J, Dreysse R, Hildebrandt AG, Fleck E: Angiotensin receptor type 1 mRNA in human right ventricular endomyocardial biopsies: downregulation in heart failure. Cardiovasc Res 1997, 35:99-105.
17. von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH: Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 1994, 89:458-470.
18. Ferrario CM: Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure? Circulation 2002, 105:1523-1525.
19. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, van Gilst WH: Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002, 105:1548-1550.
20. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T: Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003, 100:8258-8263.